Engineering the politics of Europe’s energy transformation – what will it take?
The Energiewende – is there a Nordic way?
‘Engineering the politics of Europe’s energy
‘A few humble thougths on Europe’s daunting
Independent social science/international
law research institute based in Oslo, Norway
natural resources – international level
• European energy and climate change policies
• Management of Arctic natural resources
• Russian and Chinese energy and environmental policies
• Effectiveness of international environmental cooperation
The Nordic model – relevance to energy and
The role of Norway – frozen fossile or
Input to political strategy for the future
Nordic countries differ in significant ways
Each offer unique contributions to Europe’s energy and
Integration of electricity markets source of
inspiration across countries and continents
Trust-based political systems a good starting point
Nordic ability to formulate and implement
Heritage and current surplus status demands much
of Nordic energy strategists – are we up to the
• The world’s second largest gas exporter and seventh largest
• Provides Germany, France, UK with 25-30% of their gas
imports; second only to Russia in Germany
• Major player in the emerging Arctic energy adventure, and
• Key European player also in hydro power; half of Europe’s
hydro reservoir capacity; Statkraft Europe’s largest renewable
• Provides important «green battery» functions to Denmark,
• The world’s (second?) largest sovereign wealth fund,
• The world’s largest Oil for Development Programme
report on resource politics & governance
• «The nine habits of highly effective resources
economies» (Canadian International Council, October
• «Norway is a model for Canada, indeed for any country
that wants to find out how the proceeds from winning
the geological lottery can be used for the best, long
• The ability to set goals and muster the whole society
behind comprehensive strategy for how to make
petroleum a blessing and not a curse for Norway
Norway 2012 to 2030 to 2050: part of the
• Continue long term gas sales to Europe, in support of
Europe’s efforts to reduce coal consumption
• Incentivise world leading low carbon performance
across full range petroleum production cycle
• Invest heavily in CCS, nationally but also in Europe and
• Work to eliminate gas flaring and to minimise
emissions from Arctic energy production (black carbon)
• Already major clean electricity provider to Northern
• Strategy to provide «green battery» functions to
• Implement EU’s renewables directive; green sertificates
• Exploit comparative edge in support of offshore wind
• Mobilise capital through sovereign wealth fund?
Europe key in present and even more so in
• Not sufficiently appreciated in Norway today
• Germany a leading renewable energy industry player
• Impressive long term low carbon strategy
• Energiewende sustains German low carbon ambitions
• But major obstacles ahead – is coal making a return?
EU’s pioneering role in integrating energy
• EU continues to be driving force for low carbon future
• ETS in rough weather today, but hugely important
• Moved climate concerns from PR office to boardrooms
Energy & climate outlook per October 2012
• Global emissions increasing , coal makes a «return»
• New oil & gas bonanza – can anything stop/limit the
exploitation of new fossil fuel provinces/sources?
• Global negotations stalled, low expectations for Doha
• Looming trade wars over renewable energy
• CCS stumbles ahead, setbacks and limited progress
• Financial crisis axes renewables support schemes
• ETS in rough weather as carbon price sinks further; and
• Voters/consumers get frustrated and confused
Fossil fuel sources ready for harvesting are
• already far beyond the goal of 2 percent degree warming
Who can stop the fossil fuel supertanker?
• Apple earned net income of $25,9 billion in 2011
• Apple’s property, plant and equipment worth 7,8 billion
• Exxon earned net income of $41,1 billion in 2011
• Exxon’s property, plant and equipment worth $215 billion
(«the ancien regime will not abdicate without a fight)
Sustainable crisis consciousness is needed – but
Continue investing in credible science and
Fairness and effectiveness favours targeting
carbon consumption and not production (?)
Acknowledge current crisis of confidence in
Stay the course on market-friendly reforms
Embrace China, resist protectionist pressures
Progressing towards a low carbon energy path
Get serious on coal to gas transition – reform electricity and
ensure predictable policy frameworks for gas
Accelerate CCS investments, but be frank and humble about
«Lines of contention» – paradigmatic change of speed needed in
Don’t panic, but no place for complacency over current ETS
system crisis – time to rethink the carbon tax option?
Support current renewable technologies in ways that do not lock
them in and deter essential new developments
Invest massively in new research and technology development –
energy/communication technology, improved battery functions,
electrification of transport, new electricity generation technology
It’s about people, consumers, voters – prioritise
vision, honesty, transparency, consultation
Be honest about uncertainties, costs and trade-
offs – there is no free low carbon lunch
Be tough and brave on the NIMBY phenomenon –
transmission lines are beautiful and sexy !!!!
Invest in global climate diplomacy /confidence –
find new ways of engaging Chinae and the other
Targeting the Hepatitis C virus ion channel p7 for anti-viral therapy Stephen Griffin, Dean Clarke, Steve Evans, Alastair Smith, Joachim Jäger, Introduction Hepatitis C virus (HCV) currently infects over 3 % of the world population and is the major indicator for liver transplant surgery in the west. Acute infection is usually asymptomatic but leads to persistence in the majority
2013-14 NCAA Banned Drugs It is your responsibility to check with the appropriate or designated athletics staff before using any substance The NCAA bans the following classes of drugs: a. Stimulants b. Anabolic Agents c. Alcohol and Beta Blockers (banned for rifle only) d. Diuretics and Other Masking Agents e. Street Drugs f. Peptide Hormones and Analogues g. Anti-estro